Richard C. Cilento Jr.
CIK: 0002010661
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FBLG
FibroBiologics, Inc.
Director
Discretionary Trading P&L
Holdings
About Cilento Richard C. Jr.
Cilento Richard C. Jr. (SEC CIK 0002010661) files insider reports with the SEC as Director of FibroBiologics, Inc. (FBLG).
Signal8 holds 2 ownership filings by Cilento Richard C. Jr., all Form 4s, filed between Jun 12, 2025 and Jun 23, 2026. Those filings report 2 transactions, from Jun 12, 2025 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Cilento Richard C. Jr.'s filings is in HOUSTON,, TX.
Recent filings by Cilento Richard C. Jr.
Other insiders filing for FibroBiologics, Inc. (FBLG)
- Khoja Hamid, Chief Scientific Officer
- Steinberg Leigh, Director
- Rubins Kathleen Hallisey, Director
- Hoffman Robert E., Director
- Link Matthew, Director
- Niklas Victoria Ninon Olivia, Director